ATE483689T1 - PYRAZOLE DERIVATIVES AS MODULATORS OF PROTEIN KINASE - Google Patents

PYRAZOLE DERIVATIVES AS MODULATORS OF PROTEIN KINASE

Info

Publication number
ATE483689T1
ATE483689T1 AT04806258T AT04806258T ATE483689T1 AT E483689 T1 ATE483689 T1 AT E483689T1 AT 04806258 T AT04806258 T AT 04806258T AT 04806258 T AT04806258 T AT 04806258T AT E483689 T1 ATE483689 T1 AT E483689T1
Authority
AT
Austria
Prior art keywords
group
carbon atoms
compounds
protein kinase
atoms
Prior art date
Application number
AT04806258T
Other languages
German (de)
Inventor
Valerio Berdini
Gordon Saxty
Marinus Verdonk
Steven Woodhead
Paul Wyatt
Robert Boyle
Hannah Sore
David Walker
Ian Collins
Robert Downham
Robin Carr
Original Assignee
Astex Therapeutics Ltd
Cancer Rec Tech Ltd
Cancer Res Inst Royal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Therapeutics Ltd, Cancer Rec Tech Ltd, Cancer Res Inst Royal filed Critical Astex Therapeutics Ltd
Priority claimed from PCT/GB2004/005464 external-priority patent/WO2005061463A1/en
Application granted granted Critical
Publication of ATE483689T1 publication Critical patent/ATE483689T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention provides compounds of the formula: (I) having protein kinase B inhibiting activity: wherein A is a saturated hydrocarbon linker group containing from 1 to 7 carbon atoms, the linker group having a maximum chain length of 5 atoms extending between Rand NRRand a maximum chain length of 4 atoms extending between E and NRR, wherein one of the carbon atoms in the linker group may optionally be replaced by an oxygen or nitrogen atom; and wherein the carbon atoms of the inker group A may optionally bear one or more substituents selected from oxo, fluorine and hydroxy, provided that the hydroxy group when present is not located at a carbon atom a with respect to the NRRgroup and provided that the oxo group when present is located at a carbon atom a with respect to the NRRgroup; E is a monocyclic or bicyclic carbocyclic or heterocyclic group; Ris an aryl or heteroaryl group; and R, R, Rand Rare as defined in the claims. Also provided are pharmaceutical compositions containing the compounds, methods for preparing the compounds and their use as anticancer agents.
AT04806258T 2003-12-23 2004-12-23 PYRAZOLE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ATE483689T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53219903P 2003-12-23 2003-12-23
GB0329617A GB0329617D0 (en) 2003-12-23 2003-12-23 Pharmaceutical compounds
US57784304P 2004-06-08 2004-06-08
PCT/GB2004/005464 WO2005061463A1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators

Publications (1)

Publication Number Publication Date
ATE483689T1 true ATE483689T1 (en) 2010-10-15

Family

ID=30776233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806258T ATE483689T1 (en) 2003-12-23 2004-12-23 PYRAZOLE DERIVATIVES AS MODULATORS OF PROTEIN KINASE

Country Status (11)

Country Link
CN (1) CN1922148B (en)
AT (1) ATE483689T1 (en)
DE (1) DE602004029501D1 (en)
DK (1) DK1706385T3 (en)
GB (1) GB0329617D0 (en)
ME (1) ME01934B (en)
PT (1) PT1706385E (en)
RS (1) RS51546B (en)
SI (1) SI1706385T1 (en)
UA (1) UA90461C2 (en)
ZA (1) ZA200605127B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0704932D0 (en) * 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
CN108339121A (en) * 2017-01-25 2018-07-31 苏州大学 Purposes of the protein kinase A inhibitor in preparing treatment platelet counts and increasing relevant disease drug
CN111056990B (en) * 2019-12-16 2022-06-17 爱斯特(成都)生物制药股份有限公司 Preparation method for synthesizing 1-tert-butyloxycarbonyl-4- (4-carboxyphenyl) piperidine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
CN1193026C (en) * 1999-07-30 2005-03-16 艾博特股份有限两合公司 Z-pyrazoline-5-ones

Also Published As

Publication number Publication date
SI1706385T1 (en) 2011-01-31
DK1706385T3 (en) 2011-01-10
CN1922148A (en) 2007-02-28
ZA200605127B (en) 2010-07-28
ME01934B (en) 2011-06-30
CN1922148B (en) 2012-03-21
PT1706385E (en) 2010-12-22
GB0329617D0 (en) 2004-01-28
DE602004029501D1 (en) 2010-11-18
RS51546B (en) 2011-06-30
UA90461C2 (en) 2010-05-11

Similar Documents

Publication Publication Date Title
NO20062633L (en) Pyrazole derivatives as protein kinase modulators
WO2006136837A3 (en) Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
TW200613297A (en) Pyrazole derivatives
DE602004011199D1 (en) 5-PHENYLTHIAZOL DERIVATIVES AND THEIR USE AS P13 KINASE INHIBITORS
NO20070557L (en) Phthalazine derivatives as PARP inhibitors
ATE453639T1 (en) PHENYL SUBSTITUTED PYRIMIDINE COMPOUNDS FOR USE AS KINASE INHIBITORS
WO2007125321A3 (en) Purine and deazapurine derivatives as pharmaceutical compounds
TW200611907A (en) Fused heterocyclic compound
DE602004024988D1 (en) 2-AMINOPYRIMIDINE DERIVATIVES AS RAF KINASE INHIBITORS
UA93883C2 (en) Pyrazine derivatives useful as adenosine receptor antagonists
CY1115171T1 (en) MEDICAL MEDICINE
ATE292118T1 (en) PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS
MY179032A (en) Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
ATE512957T1 (en) ACT ACTIVITY INHIBITOR
DE60328010D1 (en) HETEROCYCLIC COMPOUNDS
TW200716528A (en) Cyclopropanecarboxamide derivatives
DE602004022404D1 (en) 4-ANILINO-CHINAZOLIN DERIVATIVES AS PROLIFERATION-INHIBITABLE AGENTS
TW200618800A (en) Heterocyclic compounds
ECSP099335A (en) HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN AND METHODS OF USE OF THE SAME
AR046785A1 (en) ESTERES OF HYDROXAMIC ACID AND PHARMACEUTICAL USE OF THE SAME
NO20064238L (en) Imidazoline derivatives with CB1 agonist activity
AR047531A1 (en) DERIVATIVES 1H-TIENO (2,3-C) PIRAZOL USEFUL AS QUINASE INHIBITORS
MXPA05012247A (en) New benzimidazole derivatives.
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
TW200512201A (en) New heterocyclic amides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1706385

Country of ref document: EP